Patents by Inventor Steven C. Polomoscanik

Steven C. Polomoscanik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20240082297
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: November 10, 2023
    Publication date: March 14, 2024
    Inventors: Thomas Henry JOZEFIAK, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20230338415
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: January 9, 2023
    Publication date: October 26, 2023
    Inventors: Thomas Henry JOZEFIAK, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • Substituted phenyl boronic acid containing polymers and methods of use
    Patent number: 11576928
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: February 14, 2023
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • BENZOXABOROLE POLYMERS AND METHODS OF USE
    Publication number: 20220396651
    Abstract: The disclosure relates to benzoxaborole containing polymers and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: September 18, 2020
    Publication date: December 15, 2022
    Inventors: Thomas Henry JOZEFIAK, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • Substituted phenyl boronic acid containing polymers and methods of use
    Patent number: 11491182
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: November 8, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • Substituted phenyl boronic acid containing polymers and methods of use
    Patent number: 11491183
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: November 8, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • Substituted phenyl boronic acid containing polymers and methods of use
    Patent number: 11484548
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 1, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20220265703
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: April 7, 2022
    Publication date: August 25, 2022
    Inventors: Thomas Henry Jozefiak, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20220226366
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 21, 2022
    Inventors: Thomas Henry Jozefiak, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20220088063
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 24, 2022
    Inventors: Thomas Henry JOZEFIAK, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
    Publication number: 20220088062
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 24, 2022
    Inventors: Thomas Henry Jozefiak, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes
    Patent number: 11267924
    Abstract: Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: March 8, 2022
    Assignee: GENZYME CORPORATION
    Inventors: Pradeep K. Dhal, Robert J. Miller, Steven C. Polomoscanik, Philip Just Larsen, Thomas Huebschle, Thorsten Schmidt, Ian Davison, Peter D. McDonnell, Chinyere Agbugba
  • BORONIC ACID POLYMERS AND METHODS OF USE
    Publication number: 20210403625
    Abstract: The disclosure relates to cationic boronic acid containing polymers and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Application
    Filed: September 20, 2019
    Publication date: December 30, 2021
    Inventors: Thomas Henry JOZEFIAK, Ashish NIMGAONKAR, Steven C. POLOMOSCANIK
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190240252
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: February 4, 2019
    Publication date: August 8, 2019
    Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • CROSSLINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20160177019
    Abstract: Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 23, 2016
    Inventors: Pradeep K. DHAL, Robert J. MILLER, Steven C. POLOMOSCANIK, Philip Just LARSEN, Thomas HUEBSCHLE, Thorsten SCHMIDT, Ian DAVISON, Peter D. McDONNELL, Chinyere AGBUGBA
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160158275
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: December 14, 2015
    Publication date: June 9, 2016
    Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140322319
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m particles and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 30, 2014
    Applicant: GENZYME CORPORATION
    Inventors: Stephen Randall Holmes-Farley, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • AMIDO-AMINE DENDRIMER COMPOSITIONS
    Publication number: 20140219951
    Abstract: Amide compounds, amide polymers and compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, the amide polymers may be amido-amine dendrimers that may be formed via a series of iterative reactions.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Applicant: GENZYME CORPORATION
    Inventors: PRADEEP DHAL, S. Randall Holmes-Farley, Chad Huval, Steven C. Polomoscanik
  • SULFONE POLYMER COMPOSITIONS
    Publication number: 20130266533
    Abstract: Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containing copolymers and copolymer networks may be derived from a multi-amine-monomer and a multifunctional sulfonyl-containing monomer comprising two or more amine-reactive groups.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 10, 2013
    Inventors: Pradeep DHAL, Stephen Randall HOLMES-FARLEY, Chad HUVAL, Steven C. POLOMOSCANIK
  • SULFONE POLYMER COMPOSITIONS
    Publication number: 20100196305
    Abstract: Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containing copolymers and copolymer networks may be derived from a multi-amine monomer and a multifunctional sulfonyl-containing monomer comprising two or more amine-reactive groups.
    Type: Application
    Filed: March 5, 2008
    Publication date: August 5, 2010
    Inventors: Pradeep K. Dhal, Stephen Randall Holmes-Farley, Chad C. Huval, Steven C. Polomoscanik